Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Jay Olson initiated coverage on iBio, Inc. (NASDAQ:IBIO) with an Outperform rating and announced a price target of $5. iBio shares closed at $0.8930 on Monday. See how other analysts view this stock.
- Keybanc analyst Justin Patterson initiated coverage on Hims & Hers Health, Inc. (NYSE:HIMS) with a Sector Weight rating. Hims & Hers Health shares closed at $51.36 on Monday. See how other analysts view this stock.
- Johnson Rice analyst Martin Malloy initiated coverage on Hyliion Holdings Corp. (AMEX:HYLN) with a Buy rating and announces Price Target of $5. Hyliion Holdings shares closed at $2.13 on Monday. See how other analysts view this stock.
- Citigroup analyst Yigal Nochomovitz initiated coverage on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a Buy rating and announced a price target of $33. ACADIA Pharmaceuticals closed at $20.94 on Monday. See how other analysts view this stock.
- Guggenheim analyst Jonathan Lee initiated coverage on MARA Holdings, Inc. (NASDAQ:MARA) with a Neutral rating. MARA Holdings shares closed at $20.73 on Monday. See how other analysts view this stock.
Considering buying ACAD stock? Here’s what analysts think:
Photo via Shutterstock
